These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 13988103)
1. [Effects on the normal and pathological cerebral electrical activity of a pyrimido-pyrimidine derivative]. SERRA C; MUNICCHI L; ROTONDI SERRA F Riv Neurol; 1962; 32():536-73. PubMed ID: 13988103 [No Abstract] [Full Text] [Related]
2. Synthesis and biological evaluation of some pyrimidine, pyrimido[2,1-b][1,3]thiazine and thiazolo[3,2-a]pyrimidine derivatives. Sayed HH; Shamroukh AH; Rashad AE Acta Pharm; 2006 Jun; 56(2):231-44. PubMed ID: 16613728 [TBL] [Abstract][Full Text] [Related]
3. The synthesis and antibacterial activity of 3-alkyl derivatives of some pyrimido[4,5-d] pyrimidine. Cieplik J; Pluta J; Gubrynowicz O Acta Pol Pharm; 2003; 60(6):487-92. PubMed ID: 15080598 [TBL] [Abstract][Full Text] [Related]
4. Regiospecific one-pot synthesis of pyrimido[4,5-d]pyrimidine derivatives in the solid state under microwave irradiations. Prajapati D; Gohain M; Thakur AJ Bioorg Med Chem Lett; 2006 Jul; 16(13):3537-40. PubMed ID: 16650990 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and QSAR studies of pyrimido[4,5-d]pyrimidine-2,5-dione derivatives as potential antimicrobial agents. Sharma P; Rane N; Gurram VK Bioorg Med Chem Lett; 2004 Aug; 14(16):4185-90. PubMed ID: 15261267 [TBL] [Abstract][Full Text] [Related]
6. [Clinical and cardiographical observations on a derivative of pyrimido-pyrimidine (Persantin)]. PINO G; ACCATINO G Minerva Cardioangiol; 1961 Aug; 9():505-7. PubMed ID: 13735870 [No Abstract] [Full Text] [Related]
7. [Evaluation of the activity of a pyrimido-pyrimidine derivative in the treatment of coronary insufficiency]. NIGRO G; D'ALESSANDRO L; COMI LI Clin Ter; 1962 Nov; 23():804-14. PubMed ID: 13938596 [No Abstract] [Full Text] [Related]
8. New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: high affinity ligands for the alpha(1)-adrenoceptor subtypes. Romeo G; Materia L; Marucci G; Modica M; Pittalà V; Salerno L; Siracusa MA; Buccioni M; Angeli P; Minneman KP Bioorg Med Chem Lett; 2006 Dec; 16(24):6200-3. PubMed ID: 17027264 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial properties of 1,2,3-aryl-1,2,3,4-tetrahydropyrimido[4,5-d]pyrimidine derivatives. Cieplik J; Raginia M; Pluta J; Gubrynowicz O; Bryndal I; Lis T Acta Pol Pharm; 2008; 65(4):427-34. PubMed ID: 19051583 [TBL] [Abstract][Full Text] [Related]
11. [Clinical experiences and experimental studies on a new pyrimido-pyrimidine derivative]. KNIPPING HW; BOLT W; MIKULICZ K Arzneimittelforschung; 1960 May; 10():364-9. PubMed ID: 14410137 [No Abstract] [Full Text] [Related]
12. Synthesis and analgesic/anti-inflammatory evaluation of fused heterocyclic ring systems incorporating phenylsulfonyl moiety. Shaaban MR; Saleh TS; Mayhoub AS; Mansour A; Farag AM Bioorg Med Chem; 2008 Jun; 16(12):6344-52. PubMed ID: 18502132 [TBL] [Abstract][Full Text] [Related]
13. 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists. Shireman BT; Dvorak CA; Rudolph DA; Bonaventure P; Nepomuceno D; Dvorak L; Miller KL; Lovenberg TW; Carruthers NI Bioorg Med Chem Lett; 2008 Mar; 18(6):2103-8. PubMed ID: 18282705 [TBL] [Abstract][Full Text] [Related]
14. New piperidinyl- and 1,2,3,6-tetrahydropyridinyl-pyrimidine derivatives as selective 5-HT1A receptor agonists with highly potent anti-ischemic effects. Kamei K; Maeda N; Katsuragi-Ogino R; Koyama M; Nakajima M; Tatsuoka T; Ohno T; Inoue T Bioorg Med Chem Lett; 2005 Jun; 15(12):2990-3. PubMed ID: 15914001 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral and cytostatic evaluations of the new C-5 substituted pyrimidine and furo[2,3-d]pyrimidine 4',5'-didehydro-L-ascorbic acid derivatives. Gazivoda T; Sokcević M; Kralj M; Suman L; Pavelić K; De Clercq E; Andrei G; Snoeck R; Balzarini J; Mintas M; Raić-Malić S J Med Chem; 2007 Aug; 50(17):4105-12. PubMed ID: 17672445 [TBL] [Abstract][Full Text] [Related]
16. [CHANGES IN THE LIPEMIC PICTURE AFTER THE INTRAVENOUS INJECTION OF PYRIMIDO PYRIMIDINE DERIVATES]. DOMINGUEZLOPEZ J; FERNANDEZGARCIA JJ; PEREALOPEZ A; TALLONCANTERO R Rev Clin Esp; 1965 Jan; 96():37-41. PubMed ID: 14294603 [No Abstract] [Full Text] [Related]
17. Purification of L-asparaginase from a bacteria Erwinia carotovora and effect of a dihydropyrimidine derivative on some of its kinetic parameters. Kamble VP; Rao RS; Borkar PS; Khobragade CN; Dawane BS Indian J Biochem Biophys; 2006 Dec; 43(6):391-4. PubMed ID: 17285805 [TBL] [Abstract][Full Text] [Related]
18. A ribonucleoside with pyrimido[4,5-d]pyrimidine-2,4,5,7-(1H,3H,6H,8H)-tetraone as a nucleobase, which universally binds to natural nucleosides. Kuroda K; Kodama H; Kataoka M; Hayakawa Y Nucleic Acids Symp Ser (Oxf); 2006; (50):17-8. PubMed ID: 17150795 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, isomerization, and antimicrobial evaluation of some pyrazolopyranotriazolopyrimidine derivatives. Shamroukh AH; Zaki ME; Morsy EM; Abdel-Motti FM; Abdel-Megeid FM Arch Pharm (Weinheim); 2007 Jul; 340(7):345-51. PubMed ID: 17610300 [TBL] [Abstract][Full Text] [Related]
20. [Studies on cerebral electrical activities in pregnancy. I. Variations of cerebral electrical potentials in normal pregnancy; preliminary note]. D'ANDREA F; GERLI M Minerva Ginecol; 1954 Jun; 6(12):82. PubMed ID: 13203197 [No Abstract] [Full Text] [Related] [Next] [New Search]